Table 2.
Pharmacists’ inquiries and recommendations in response to the simulated clinical scenarios
| Simulated clinical scenario | Explained how to take the antibiotic | Explained the duration of treatment | Asked about drug allergy | Asked about concomitant use of other drugs | Recommended consulting a physician | Dispensed antibiotic |
|---|---|---|---|---|---|---|
| Sore throat, n=40 | 35 (87.5%) | 7 (17.5%) | 18 (45%) | 1 (2.5%) | 0 (0%) | Penicillins (45%) |
| Penicillin/penicillinase inhibitor (32.5%) | ||||||
| First-Gen cephalosporins (10%) | ||||||
| Acute sinusitis, n=15 | 14 (93.3%) | 1 (6.7%) | 4 (26.7%) | 4 (26.7%) | 0 (0%) | Penicillins (20%) |
| Fluoroquinolones (20%) | ||||||
| Macrolides (20%) | ||||||
| Otitis media, n=26 | 26 (100%) | 3 (11.5%) | 0 (0%) | 3 (11.5%) | 4 (15.4%) | Choramphenicol (19.2%) |
| Penicillins (15.4%) | ||||||
| Macrolides (11.5%) | ||||||
| Diarrhea, n=34 | 34 (100%) | 7 (20.6%) | 0 (0%) | 0 (0%) | 1 (2.9%) | Antiprotozoals (79.4%) |
| Sulfonamides (5.9%) | ||||||
| FQ (2.9%) | ||||||
| UTI, n=35 | 34 (97.1%) | 7 (20%) | 1 (2.9%) | 0 (0%) | 1 (2.9%) | Fluoroquinolones (80%) |
| Third-Gen cephalosporins (5.7%) |
Abbreviations: UTI, urinary tract infection; Gen, generation; FQ, fluoroquinolones.